Luminex Corp (LMNX)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Luminex Corp (LMNX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013941
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Luminex Corp (Luminex) is a medical devices company which develops, manufactures and markets proprietary biological testing technologies. The company offers wide range of products including instruments, assays, reagents and accessories, software and replacement parts. Its proprietary technologies consist of xMAP technology, xTAG and MultiCode technology. Luminex offers its products to various markets such as clinical diagnostics; pharmaceutical drug discovery; biomedical research including personalized medicine, genomic and proteomic research, biodefense research and food safety. The company sells its products through direct sales channel and strategic distribution partners in North America, Europe and Asia-Pacific. Luminex is headquartered in Texas, the US.

Luminex Corp (LMNX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Luminex Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Luminex Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Luminex Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Luminex Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Luminex Corp, Medical Devices Deals, 2011 to YTD 2017 9
Luminex Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Luminex Corp, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Luminex Extends Distribution Agreement With EMD Millipore 11
Equity Offering 12
Nanosphere Raises USD10 Million in Public Offering of Shares 12
Nanosphere to Raise USD4.4 Million in Private Placement of Convertible Preferred Stock 14
Nanosphere Raises USD4.4 Million in Private Placement of Series A Convertible Preferred Stock 15
Acquisition 16
Luminex Acquires Nanosphere in Tender Offer 16
Luminex Corp – Key Competitors 18
Luminex Corp – Key Employees 19
Luminex Corp – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 22
Financial Announcements 22
Oct 30, 2017: Luminex Reports Third Quarter 2017 Financial Results 22
Aug 07, 2017: Luminex Reports Second Quarter 2017 Financial Results 23
May 01, 2017: Luminex Reports Record First Quarter 2017 Financial Results; Raises 2017 Financial Guidance 24
Feb 06, 2017: Luminex Reports Fourth Quarter And Full Year 2016 Results 25
Jan 09, 2017: Luminex Announces Preliminary Revenue for Fourth Quarter 2016 and Issues 2017 Revenue Guidance 26
Oct 31, 2016: Luminex Reports Third Quarter 2016 Results; Raises Full Year Guidance 27
Jul 28, 2016: Luminex Reports Second Quarter 2016 Results 28
May 02, 2016: Luminex Reports First Quarter 2016 Results 29
Feb 01, 2016: Luminex Reports Fourth Quarter And Full Year 2015 Results 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Luminex Corp, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Luminex Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Luminex Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Luminex Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Luminex Corp, Deals By Therapy Area, 2011 to YTD 2017 8
Luminex Corp, Medical Devices Deals, 2011 to YTD 2017 9
Luminex Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Luminex Extends Distribution Agreement With EMD Millipore 11
Nanosphere Raises USD10 Million in Public Offering of Shares 12
Nanosphere to Raise USD4.4 Million in Private Placement of Convertible Preferred Stock 14
Nanosphere Raises USD4.4 Million in Private Placement of Series A Convertible Preferred Stock 15
Luminex Acquires Nanosphere in Tender Offer 16
Luminex Corp, Key Competitors 18
Luminex Corp, Key Employees 19
Luminex Corp, Other Locations 20
Luminex Corp, Subsidiaries 20

★海外企業調査レポート[Luminex Corp (LMNX)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sorrento Therapeutics Inc (SRNE):製薬・医療:M&Aディール及び事業提携情報
    Summary Sorrento Therapeutics Inc (STI), formerly QuikByte Software Inc, is a cancer therapeutic service provider. The company offers CD38 CAR-T, lidocaine topical system, resiniferatoxin. Its product pipeline includes CD38 CAR-T, CEA CAR-T, CD38 ADC and seprehvir. STI provides treatment for multipl …
  • Marquard & Bahls AG:企業の戦略・SWOT・財務分析
    Marquard & Bahls AG - Strategy, SWOT and Corporate Finance Report Summary Marquard & Bahls AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Siegfried Holding AG (SFZN)-製薬・医療分野:企業M&A・提携分析
    Summary Siegfried Holding AG (Siegfried) is a custom manufacturing organization (CMO). The company is active in the primary and secondary production of drugs. It develops and manufactures active pharmaceutical ingredients (APIs) for the research-based pharmaceutical industry and corresponding interm …
  • Vexim SA – Product Pipeline Analysis, 2018 Uate
    Summary Vexim SA (Vexim), a subsidiary of Stryker Corp, is a healthcare product manufacturer that provides solutions for patients suffering from vertebral compression fractures. The company provides solutions such as controlled anatomical restoration and advanced vertebroplasty therapy. Its controll …
  • Medical Transcription Billing Corp (MTBC):医療機器:M&Aディール及び事業提携情報
    Summary Medical Transcription Billing Corp (MTBC) is a healthcare IT company that offers web-based solutions and related business services. The company offers products such as electronic health records, practice management, patient engagement and mhealth. Its services include offers medical billing, …
  • A&R Carton AB:企業の戦略・SWOT・財務情報
    A&R Carton AB - Strategy, SWOT and Corporate Finance Report Summary A&R Carton AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Broadridge Financial Solutions, Inc.:企業の戦略・SWOT・財務分析
    Broadridge Financial Solutions, Inc. - Strategy, SWOT and Corporate Finance Report Summary Broadridge Financial Solutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • AerCap Holdings NV:企業の戦略・SWOT・財務情報
    AerCap Holdings NV - Strategy, SWOT and Corporate Finance Report Summary AerCap Holdings NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • CITIC Ltd (267)-エネルギー分野:企業M&A・提携分析
    Summary CITIC Limited (CITIC) is a conglomerate that is active in diverse business areas such as financial services, resources and energy, manufacturing, engineering contracting, and real estate and infrastructure. Its financial services include banking, trust, asset management, securities and insur …
  • Cegedim SA (CGM):企業の財務・戦略的SWOT分析
    Summary Cegedim SA (Cegedim) is a technology company that offers healthcare technical services. The company offers solutions to facilitate business and medical operations. It offers health and preventive health management software used in management of individual and collective health and preventive …
  • Inhibrx LP:製薬・医療:M&Aディール及び事業提携情報
    Summary Inhibrx LP (Inhibrx) is a biotherapeutic company that develops drugs for treatment of oncology, infectious disease and inflammatory diseases. The company’s products include therapeutic proteins with multivalent and multi specific molecules which are designed from their antibody technology. I …
  • Neurelis Inc-製薬・医療分野:企業M&A・提携分析
    Summary Neurelis Inc. (Neurelis) is a specialty pharmaceutical company, which develops medicines to target unmet medical need in epilepsy and acute anxiety episodes. The company's product portfolio includes NRL-1 (intranasal diazepam), a proprietary formulation, for epilepsy in pediatric and adult p …
  • Breko GmbH:企業の戦略・SWOT・財務分析
    Breko GmbH - Strategy, SWOT and Corporate Finance Report Summary Breko GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Toshiba Semiconductor Company:企業の戦略的SWOT分析
    Toshiba Semiconductor Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Pioneer Food Group Ltd:企業の戦略・SWOT・財務情報
    Pioneer Food Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Pioneer Food Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Manz AG (M5Z):電力:M&Aディール及び事業提携情報
    Summary Manz AG (Manz) is a manufacturer of high-technology equipment. It produces displays, printed circuit boards and other components for electronic devices. The company provides production equipment for lithium-ion battery cells, super capacitors, battery systems, and capacitors. Manz offers ind …
  • Gavis Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析
    Summary Gavis Pharmaceuticals LLC (GAVIS), a subsidiary of Lupin Ltd is a healthcare products provider that develops, markets and distributes tablets and oral solutions. The company offers products such as cetrizine hydrochloride, clobetasol propionate, dexmethylphenidate hydrochloride, dextroamphet …
  • American Outdoor Brands Corp:企業の戦略・SWOT・財務情報
    American Outdoor Brands Corp - Strategy, SWOT and Corporate Finance Report Summary American Outdoor Brands Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • SNC-Lavalin Group Inc (SNC)-石油・ガス分野:企業M&A・提携分析
    Summary SNC-Lavalin Group Inc. (SNC) is global provider of engineering and construction services. It offers a range of engineering, procurement, construction, project management services to various industries, including oil and gas, mining and metallurgy, infrastructure and power. In addition, the c …
  • Altavia SA:企業の戦略的SWOT分析
    Altavia SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆